Squarepoint Ops LLC Adma Biologics, Inc. Transaction History

Squarepoint Ops LLC

  • $99.2 Billion
  • Q4 2024

A detailed history of Squarepoint Ops LLC transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Squarepoint Ops LLC holds 287,864 shares of ADMA stock, worth $4.47 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
287,864
Previous 355,288 18.98%
Holding current value
$4.47 Million
Previous $7.1 Million 30.5%
% of portfolio
0.0%
Previous 0.01%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
SELL
$15.62 - $22.62 $1.05 Million - $1.53 Million
-67,424 Reduced 18.98%
287,864 $4.94 Million
Q3 2024

Nov 14, 2024
BUY
$11.21 - $20.03 $23,451 - $41,902
2,092 Added 0.59%
355,288 $7.1 Million
Q2 2024

Aug 14, 2024
BUY
$5.98 - $11.18 $831,040 - $1.55 Million
138,970 Added 64.87%
353,196 $3.95 Million
Q1 2024

May 15, 2024
SELL
$4.4 - $6.74 $215,564 - $330,206
-48,992 Reduced 18.61%
214,226 $1.41 Million
Q4 2023

Feb 14, 2024
BUY
$3.08 - $4.52 $680,581 - $998,775
220,968 Added 523.0%
263,218 $1.19 Million
Q2 2023

Aug 14, 2023
BUY
$3.12 - $4.22 $131,820 - $178,295
42,250 New
42,250 $155,000
Q4 2022

Feb 14, 2023
BUY
$2.47 - $3.88 $72,454 - $113,815
29,334 New
29,334 $113,000
Q2 2022

Aug 15, 2022
SELL
$1.43 - $2.2 $257,394 - $395,991
-179,996 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$1.28 - $1.83 $187,342 - $267,840
146,361 Added 435.14%
179,996 $329,000
Q4 2021

Feb 14, 2022
SELL
$1.09 - $1.66 $63,537 - $96,763
-58,291 Reduced 63.41%
33,635 $47,000
Q3 2021

Nov 15, 2021
SELL
$1.13 - $1.65 $228,184 - $333,189
-201,933 Reduced 68.72%
91,926 $104,000
Q2 2021

Aug 16, 2021
SELL
$1.51 - $2.07 $425,013 - $582,634
-281,466 Reduced 48.92%
293,859 $470,000
Q1 2021

May 17, 2021
BUY
$1.67 - $2.95 $756,550 - $1.34 Million
453,024 Added 370.42%
575,325 $1.01 Million
Q4 2020

Feb 16, 2021
BUY
$1.8 - $2.56 $188,271 - $267,763
104,595 Added 590.73%
122,301 $238,000
Q3 2020

Nov 16, 2020
SELL
$2.04 - $3.74 $125,945 - $230,900
-61,738 Reduced 77.71%
17,706 $42,000
Q2 2020

Aug 14, 2020
BUY
$2.42 - $3.29 $146,318 - $198,919
60,462 Added 318.52%
79,444 $233,000
Q1 2020

May 15, 2020
SELL
$1.5 - $4.59 $20,365 - $62,318
-13,577 Reduced 41.7%
18,982 $55,000
Q4 2019

Feb 14, 2020
BUY
$3.89 - $5.15 $126,654 - $167,678
32,559 New
32,559 $130,000
Q4 2018

Feb 14, 2019
SELL
$2.17 - $6.12 $25,172 - $70,992
-11,600 Closed
0 $0
Q3 2018

Nov 14, 2018
BUY
$4.39 - $6.85 $2,432 - $3,794
554 Added 5.02%
11,600 $72,000
Q2 2018

Aug 14, 2018
BUY
$4.39 - $5.44 $48,491 - $60,090
11,046 New
11,046 $50,000

Others Institutions Holding ADMA

# of Institutions
339
Shares Held
182M
Call Options Held
1.72M
Put Options Held
846K
View Full List

About ADMA BIOLOGICS, INC.

ADMA Quotes by TradingView
  • Ticker ADMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 196,356,992
  • Market Cap $3.05B
  • Description
  • ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...
More about ADMA
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email